On June 15, the NIH officially launched ORIVA — the Office of Research Innovation, Validation, and Application — a new federal office dedicated to developing and scaling research methods that don't use live animals. The office will coordinate development of what scientists call New Approach Methodologies: 3D human tissue models, organoids, AI-driven analysis, and computational modeling that can replicate what animal studies attempt to measure. For dogs specifically, this shift matters more than it might look.

The same animal models used to establish nutritional standards for commercial pet food are the ones now being phased out.

ORIVA is not a research lab. It's a coordination office.

Its job is to move technologies that already exist in academic settings into mainstream NIH-funded research — faster than the current system allows. That means setting validation standards, funding development of human-based test platforms, and pushing federal agencies to accept results from organoids and computational models the same way they currently accept results from mice. The office covers everything from drug safety testing to nutrition science to environmental health research.

The launch didn't come from nowhere. It follows years of high-profile failures — including the collapse of dozens of Alzheimer's drug candidates that worked perfectly in mouse models and then did nothing in human trials.

The mouse model's failure rate in Alzheimer's research sits near 90%.

That number has been known for years. Treatments that reduce plaques in mice, reverse cognitive symptoms in mice, and extend mouse lifespan at remarkable rates have repeatedly failed at the first stage of human trials. The biological gap between rodents and humans is large enough that many researchers have argued the mouse model is not just imperfect — it's actively misleading. It generates data that looks like progress while the actual disease mechanism remains untouched.

The same problem exists in nutrition research. Most of what is understood about macronutrient metabolism, dietary adequacy, and long-term health outcomes in animals was established through rodent studies conducted under controlled lab conditions that bear little resemblance to how companion animals actually live and eat.

The technologies ORIVA is designed to accelerate are already producing results in research settings.

Organoids — miniature, lab-grown versions of human organs built from stem cells — can replicate how a liver processes a toxin or how a brain cell responds to inflammation in ways that mouse tissue cannot. Microphysiological systems, sometimes called organs-on-chips, link several organoids together to model how compounds move through multiple organ systems. AI-driven computational models can simulate biological responses at a molecular level, predicting toxicity and efficacy without a single animal being involved. These methods aren't experimental — they're in use. The bottleneck has been regulatory acceptance, not scientific readiness.

ORIVA's mandate is to close that gap.

The week ORIVA launched, two other stories ran alongside it.

The Dog Aging Project — a nationwide study of more than 53,000 companion dogs — was drawing national attention for using dogs not as lab subjects, but as voluntary participants living normal lives with their owners. And Ridglan Farms, a Wisconsin beagle breeding facility that supplied research labs for decades, announced permanent closure after years of protests and a federal plea agreement. The same week produced a federal office to end the old model, a study proving the ethical model works, and the closure of one of its most visible symbols.

The cognitive research coming out of the Dog Aging Project shows what's possible when dogs participate in science without being harmed by it. ORIVA is designed to make that the rule rather than the exception — replacing the system that put beagles in breeding facilities with one that uses human tissue and computational modeling instead.

For dog owners, the practical implication is this: the nutritional and safety claims attached to ultra-processed pet food were validated largely through the same animal-model pipeline ORIVA is being built to replace. What gets studied differently going forward may look very different from what the industry has spent decades defending.

KibbleFacts.com All rights reserved. Kibble Facts believes every dog deserves an advocate, and every dog owner deserves clear, trustworthy guidance. From uncovering what’s really in commercial pet food to sharing practical tips on nutrition, wellness, behavior, aging, and the everyday joys of caring for your dog or cat, we’re here to make pet care feel less confusing and a lot more empowering.